TGF-β2 silencing to target biliary-derived liver diseases
Dropmann, Anne, Dooley, Steven, Dewidar, Bedair, Hammad, Seddik, Dediulia, Tatjana, Werle, Julia, Hartwig, Vanessa, Ghafoory, Shahrouz, Woelfl, Stefan, Korhonen, Hanna, Janicot, Michel, Wosikowski, Katja, Itzel, Timo, Teufel, Andreas, Schuppan, Detlef, Stojanovic, Ana
, Cerwenka, Adelheid, Nittka, Stefanie, Piiper, Albrecht, Gaiser, Timo, Beraza, Naiara
, Milkiewicz, Malgorzata, Milkiewicz, Piotr, Brain, John G., Jones, David E. J., Weiss, Thomas S.
, Zanger, Ulrich M., Ebert, Matthias and Meindl-Beinker, Nadja M.
(2020)
TGF-β2 silencing to target biliary-derived liver diseases.
Gut 69 (9), pp. 1677-1690.
Date of publication of this fulltext: 11 Oct 2021 12:44
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Gut | ||||
| Publisher: | BMJ PUBLISHING GROUP | ||||
|---|---|---|---|---|---|
| Place of Publication: | LONDON | ||||
| Volume: | 69 | ||||
| Number of Issue or Book Chapter: | 9 | ||||
| Page Range: | pp. 1677-1690 | ||||
| Date | 2020 | ||||
| Institutions | Medicine > Lehrstuhl für Kinder- und Jugendmedizin | ||||
| Identification Number |
| ||||
| Keywords | GROWTH-FACTOR-BETA; ANTISENSE OLIGONUCLEOTIDE; SCLEROSING CHOLANGITIS; URSODEOXYCHOLIC ACID; IMMUNE REGULATION; NATURAL-HISTORY; IN-VITRO; EXPRESSION; FIBROSIS; PATHWAY; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 49725 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric